Immunomodulatory and Anti-Inflammatory Potential of Curcumin for the Treatment of Allergic Asthma: Effects on Expression Levels of Pro-inflammatory Cytokines and Aquaporins
- 33 Downloads
Curcumin is well known for possessing anti-inflammatory properties and for its beneficial effects in the treatment of asthma. Current study investigates the immunomodulatory and anti-inflammatory effects of curcumin using mouse model of ovalbumin-induced allergic asthma. BALB/c mice were immunized with ovalbumin on day 0 and 14 to induce allergic asthma. Animals were treated with two different doses of curcumin (20 mg/kg and 100 mg/kg) and methylprednisolone from day 21 to 28. Mice were also daily challenged intranasally with ovalbumin during treatment period, and all groups were sacrificed at day 28. Histopathological examination showed amelioration of allergic asthma in treated groups as evident by the attenuation of infiltration of inflammatory cells, goblet cell hyperplasia, alveolar thickening, and edema and vascular congestion. Curcumin significantly reduced total and differential leukocyte counts in both bronchoalveolar lavage fluid and blood. Reverse transcription polymerase chain reaction analysis showed significantly suppressed mRNA expression levels of IL-4 and IL-5 (pro-inflammatory cytokines), TNF-α, TGF-β (pro-fibrotic cytokines), eotaxin (chemokine), and heat shock protein 70 (marker of airway obstruction) in treated groups. Attenuation of these pro-inflammatory markers might have led to the suppression of airway inflammation. The expression levels of aquaporin-1 (AQP) and AQP-5 were found significantly elevated in experimental groups which might be responsible for reduction of pulmonary edema. In conclusion, curcumin significantly ameliorated allergic asthma. The anti-asthmatic effect might be attributed to the suppression of pro-inflammatory cytokines, and elevation of aquaporin expression levels, suggesting further studies and clinical trials to establish its candidature in the treatment of allergic asthma.
KEY WORDSairway inflammation Curcumin longa pulmonary edema Th2 cytokines
The authors would like to thank Department of Hematology, Department of Biochemistry, Department of Morbid Anatomy and Histopathology, Department of Immunology, and Resource Lab for providing technical support.
Compliance with Ethical Standards
Approvals of all the experimental protocols were taken from the Ethical Review Committee, University of Health Sciences, Lahore.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 1.Ishmael, F.T. 2011. The inflammatory response in the pathogenesis of asthma. The Journal of the American Osteopathic Association 111: S11–S17.Google Scholar
- 2.Akinbami, L.J., J.E. Moorman, C. Bailey, H.S. Zahran, M. King, C.A. Johnson, and X. Liu. 2012. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief 94: 1–8.Google Scholar
- 3.Dhami, S., A. Kakourou, F. Asamoah, I. Agache, S. Lau, M. Jutel, A. Muraro, G. Roberts, C.A. Akdis, M. Bonini, O. Cavkaytar, B. Flood, P. Gajdanowicz, K. Izuhara, Ö. Kalayci, R. Mosges, O. Palomares, O. Pfaar, S. Smolinska, M. Sokolowska, M. Asaria, G. Netuveli, H. Zaman, A. Akhlaq, and A. Sheikh. 2017. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy. 72 (12): 1825–1848.CrossRefGoogle Scholar
- 5.Kampen, G.T., S. Stafford, T. Adachi, T. Jinquan, S. Quan, J.A. Grant, P.S. Skov, L.K. Poulsen, and R. Alam. 2000. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood. 95: 1911–1917.Google Scholar
- 8.Rana, S., M. Shahzad, and A. Shabbir. 2016. Pistacia integerrima ameliorates airway inflammation by attenuation of TNF- α, IL-4, and IL-5 expression levels, and pulmonary edema by elevation of AQP1 and AQP5 expression levels in mouse model of ovalbumin-induced allergic asthma. Phytomedicine. 23: 838–845.CrossRefGoogle Scholar
- 9.Dong, C., G. Wanga, B. Li, K. Xiaoa, Z. Mab, H. Huangd, X. Wanga, and C. Chunxue Baia. 2012. Anti-asthmatic agents alleviate pulmonary edema by upregulating AQP1 and AQP5 expression in the lungs of mice with OVA-induced asthma. J. Resp. 181: 21–28.Google Scholar
- 10.Changchun, H., Z. Haijin, Li Wenjun, L. Zhenyu, Z. Dan, L. Laiyu, T. Wancheng, C. Shao-xi, and Z. Fei. Increased heat shock protein 70 levels in induced sputum and plasma correlate with severity of asthma patients. Cell Stress & Chaperones 16 (6): 663–671.Google Scholar
- 13.Abbas, A.T., M.M. Abdel-Aziz, K.R. Zalata, and D. Abd Al-Galel Tel. 2005. Effect of dexamethasone and Nigella sativa on peripheral blood eosinophil count, IgG1 and IgG2a, cytokine profiles and lung inflammation in murine model of allergic asthma. The Egyptian Journal of Immunology 12: 95–102.Google Scholar
- 15.Pawar, R.S., F.A. Toppo, A.S. Mandloi, and S. Shaikh. Exploring the role of curcumin containing ethanolic extract obtained from Curcuma longa (rhizomes) against retardation of wound healing process by aspirin. Indian. J. Pharmacol 47 (2): 160–166.Google Scholar
- 17.Jurenka, J.S. 2009. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Alternative Medicine Review 14 (2): 141–153.Google Scholar
- 18.Abidi, A., S. Gupta, M. Agarwal, H.L. Bhalla, and M. Saluja. 2014. Evaluation of efficacy of curcumin as an add-on therapy in patients of bronchial asthma. Journal of Clinical and Diagnostic Research 8 (8): HC19–HC24.Google Scholar
- 23.Zhu, T., Z. Chen, G. Chen, D. Wang, S. Tang, H. Deng, J. Wang, S. Li, J. Lan, J. Tong, H. Li, X. Deng, W. Zhang, J. Sun, Y. Tu, W. Luo, and C. Li. 2019 Apr 3. Curcumin attenuates asthmatic airway inflammation and mucus hypersecretion involving a PPARγ-dependent NF-κB signaling pathway in vivo and in vitro. Mediators of Inflammation 2019: 4927430–4927415. https://doi.org/10.1155/2019/4927430.Google Scholar
- 28.Tirado-Rodriguez, B., E. Ortega, P. Segura-Medina, and S. Huerta-Yepez. 2014. TGF-β: An important mediator of allergic disease and a molecule with dual activity in cancer development. J. Immunol. Res. Article ID 318481.Google Scholar
- 33.Aït-Khaled, N., G. Auregan, N. Bencharif, L.M. Camara, E. Dagli, K. Djankine, B. Keita, C. Ky, S. Mahi, K. Ngoran, D.L. Pham, O. Sow, M. Yousser, N. Zidouni, and D.A. Enarson. 2000. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. The International Journal of Tuberculosis and Lung Disease 4 (3): 268–271.Google Scholar
- 35.Zhang, X.Y., J.L. Simpson, H. Powell, I.A. Yang, J.W. Upham, P.N. Reynolds, S. Hodge, A.L. James, C. Jenkins, M.J. Peters, J.T. Lin, and P.G. Gibson. 2014. Full blood count parameters for the detection of asthma inflammatory phenotypes. Clinical and Experimental Allergy 44 (9): 1137–1145.Google Scholar
- 36.Robinson, D.S., A.B. Kay, and A.J. Wardlaw. 2002. Eosinophils. Clinical Allergy and Immunology 16: 43–75.Google Scholar
- 37.Walford, H.H., and T.A. Doherty. 2014. Diagnosis and management of eosinophilic asthma: A US perspective. Journal Asthma Allergy 7: 53–65.Google Scholar
- 42.Zhang, J., L. Gong, B. Hasan, J. Wang, J. Luo, H. Ma, and F. Li. 2015. Use of aquaporins 1 and 5 levels as a diagnostic marker in mild-to-moderate adult-onset asthma. International Journal of Clinical and Experimental Pathology 8 (11): 14206–14213.Google Scholar
- 43.Jassim, A.N., S.A. Brakhas, and A.J. Hassan. 2015. Study of serum interleukin 33 and heat shock protein70 in allergic disease. International Journal of Advanced Research 3 (2): 715–719.Google Scholar